BICALUTAMIDE for Hormone-refractory prostate cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 87 adverse event reports in the FDA FAERS database where BICALUTAMIDE was used for Hormone-refractory prostate cancer.
Most Reported Side Effects for BICALUTAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 352 | 8.7% | 52 | 43 |
| Prostatic specific antigen increased | 322 | 7.9% | 18 | 41 |
| Drug ineffective | 268 | 6.6% | 46 | 38 |
| Fatigue | 258 | 6.4% | 22 | 79 |
| Prostate cancer | 258 | 6.4% | 35 | 74 |
| Asthenia | 223 | 5.5% | 6 | 57 |
| Hot flush | 219 | 5.4% | 10 | 21 |
| Off label use | 171 | 4.2% | 21 | 51 |
| Disease progression | 169 | 4.2% | 26 | 28 |
| Anaemia | 164 | 4.0% | 35 | 86 |
| Death | 164 | 4.0% | 164 | 24 |
| Metastases to bone | 164 | 4.0% | 26 | 23 |
| Dyspnoea | 128 | 3.2% | 15 | 61 |
| Nausea | 127 | 3.1% | 5 | 45 |
| Interstitial lung disease | 118 | 2.9% | 41 | 65 |
Other Indications for BICALUTAMIDE
Prostate cancer (1,832)
Product used for unknown indication (732)
Prostate cancer metastatic (338)
Antiandrogen therapy (45)
Metastases to bone (38)
Hormone-dependent prostate cancer (32)
Salivary gland cancer (31)
Prostatic specific antigen increased (25)
Hormone therapy (21)
Adenocarcinoma (20)
Other Drugs Used for Hormone-refractory prostate cancer
ENZALUTAMIDE (8,881)
RADIUM RA-223 DICHLORIDE (1,615)
ABIRATERONE (1,378)
DOCETAXEL (674)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (579)
DAROLUTAMIDE (553)
CABAZITAXEL (524)
PREDNISONE (474)
APALUTAMIDE (365)
OLAPARIB (313)